Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million
05/08/2026 21:06
BRIEF-Cytek Biosciences Q2 Revenue USD 48.14 Million Aug 05 (Reuters) - Cytek Biosciences Q2 adjusted gross margin 59%.
- Q2 adjusted EBITDA USD -1.541 million
- Q2 pretax profit USD -11.643 million
- Q2 net income USD -12.158 million
- outlook FY revenue USD 207-212 million vs. IBES estimate USD 208.8 million
Recent news on Cytek Biosciences
See all newsCytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says (updated)
Cytek owes Beckman Coulter $56 mln in cell-analysis patent case, US jury says
Cytek Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Cytek Biosciences Q2 revenue slightly misses estimates
Brief: Cytek Biosciences Q2 Revenue USD 48.14 Million